but thats not what you said. You have invested a heck of a lot of time on par research and building a fan base. I think if you are genuine then you might need to think about how you represent things esp when they are clearly wrong. Pharma are waiting on fda to signoff before doing a deal. par are not the gatekeepers stopping a deal. Par is not the power player in this negotiation atm. That could change post fda approval for p3 but it isnt the dynamic atm.
Sharewise Presentation 22/7/24, page-38
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.015(7.50%) |
Mkt cap ! $75.30M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.5¢ | $101.7K | 477.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 109430 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 66388 | 5 |
View Market Depth
| Last trade - 14.47pm 03/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |